These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8116175)

  • 1. Use of tamoxifen in control of canine mammary neoplasia.
    Singleton P
    Vet Rec; 1993 Dec; 133(24):602. PubMed ID: 8116175
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of tamoxifen in control of canine mammary neoplasia.
    Ruben J
    Vet Rec; 1993 Dec; 133(24):602. PubMed ID: 8116174
    [No Abstract]   [Full Text] [Related]  

  • 3. [Estrogen antagonists in the dog].
    Ungemach FR
    Tierarztl Prax; 1992 Jun; 20(3):248. PubMed ID: 1496517
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of tamoxifen in the control of canine mammary neoplasia.
    Baker RW
    Vet Rec; 1994 Jan; 134(1):24. PubMed ID: 8128569
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of tamoxifen in the control of canine mammary neoplasia.
    Morris JS; Dobson JM; Bostock DE
    Vet Rec; 1993 Nov; 133(22):539-42. PubMed ID: 8116156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugated linoleic acid (CLA) modulates prostaglandin E2 (PGE2) signaling in canine mammary cells.
    Wang LS; Huang YW; Liu S; Chang HL; Ye W; Shu S; Sugimoto Y; Funk JA; Smeaks DD; Hill LN; Lin YC
    Anticancer Res; 2006; 26(2A):889-98. PubMed ID: 16619484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
    Faustino AM; van Garderen E; Schalken JA; Nederbragt H
    J Comp Pathol; 2002 Jan; 126(1):1-8. PubMed ID: 11814316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine mammary tumour cell lines established in vitro.
    Hellmén E
    J Reprod Fertil Suppl; 1993; 47():489-99. PubMed ID: 8229968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and activity of transglutaminase II in spontaneous tumours of dogs and cats.
    Wakshlag JJ; McNeill CJ; Antonyak MA; Boehm JE; Fuji R; Balkman CE; Zgola M; Cerione RA; Page RL
    J Comp Pathol; 2006; 134(2-3):202-10. PubMed ID: 16615935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma.
    Heller DA; Clifford CA; Goldschmidt MH; Holt DE; Shofer FS; Smith A; Sorenmo KU
    Vet Pathol; 2005 Nov; 42(6):776-80. PubMed ID: 16301573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloprotease-2 (MMP-2) and the activator membrane type 1 (MT1-MMP) in canine mammary carcinomas.
    Papparella S; Restucci B; Paciello O; Maiolino P
    J Comp Pathol; 2002 May; 126(4):271-6. PubMed ID: 12056775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours.
    Jakab C; Halász J; Szász AM; Kiss A; Schaff Z; Rusvai M; Gálfi P; Kulka J
    J Comp Pathol; 2008 Nov; 139(4):238-45. PubMed ID: 18848337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to treatment of lymphangiosarcoma in a boxer dog.
    Marcinowska A; Warland J; Brearley M; Dobson J
    J Small Anim Pract; 2013 Jun; 54(6):334-7. PubMed ID: 23560802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic status of p53 gene mutation in canine mammary carcinoma.
    Wakui S; Muto T; Yokoo K; Yokoo R; Takahashi H; Masaoka T; Hano H; Furusato M
    Anticancer Res; 2001; 21(1B):611-6. PubMed ID: 11299814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metallothionein expression in benign and malignant canine mammary gland tumours.
    Erginsoy SD; Sozmen M; Caldin M; Furlanello T
    Res Vet Sci; 2006 Aug; 81(1):46-50. PubMed ID: 16289156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.
    Sorenmo KU; Kristiansen VM; Cofone MA; Shofer FS; Breen AM; Langeland M; Mongil CM; Grondahl AM; Teige J; Goldschmidt MH
    Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic features of mammary invasive micropapillary carcinoma (IMC) in dogs.
    Gama A; Alves A; Schmitt FC
    Vet Pathol; 2008 Jul; 45(4):600-1. PubMed ID: 18587110
    [No Abstract]   [Full Text] [Related]  

  • 19. Animal model of human disease: canine mammary neoplasia.
    Strandberg JD; Goodman DG
    Am J Pathol; 1974 Apr; 75(1):225-8. PubMed ID: 4825616
    [No Abstract]   [Full Text] [Related]  

  • 20. Spontaneous mammary intraepithelial lesions in dogs--a model of breast cancer.
    Antuofermo E; Miller MA; Pirino S; Xie J; Badve S; Mohammed SI
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2247-56. PubMed ID: 17982119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.